APOE and Alzheimer disease: For optimal and generalizable operationalization of such imputation approaches for the presence of AD Aβ pathology, it is important to assess the independent and added value of each class of predictors (e.g. demographics, APOE ε4, cognition, plasma biomarkers, MRI, etc.)and the differences in their classification performances at different clinical stages.